These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 39125814)

  • 1. Large-Scale Screening of Per- and Polyfluoroalkyl Substance Binding Interactions and Their Mixtures with Nuclear Receptors.
    Roy S; Moran J; Danasekaran K; O'Brien K; Dakshanamurthy S
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual screening of potentially endocrine-disrupting chemicals against nuclear receptors and its application to identify PPARγ-bound fatty acids.
    Jaladanki CK; He Y; Zhao LN; Maurer-Stroh S; Loo LH; Song H; Fan H
    Arch Toxicol; 2021 Jan; 95(1):355-374. PubMed ID: 32909075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Potential Endocrine Disrupting Chemicals Binding to Estrogen Receptor α (ERα) Using a Pipeline Combining Structure-Based and Ligand-Based in Silico Methods.
    Sellami A; Montes M; Lagarde N
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric Binding Sites On Nuclear Receptors: Focus On Drug Efficacy and Selectivity.
    Fischer A; Smieško M
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactivity profiling of per- and polyfluoroalkyl substances (PFAS) identifies potential toxicity pathways related to molecular structure.
    Houck KA; Patlewicz G; Richard AM; Williams AJ; Shobair MA; Smeltz M; Clifton MS; Wetmore B; Medvedev A; Makarov S
    Toxicology; 2021 Jun; 457():152789. PubMed ID: 33887376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Modeling of Allosteric Site of Isoform-Specific Inhibition of the Peroxisome Proliferator-Activated Receptor PPARγ.
    Almahmoud S; Zhong HA
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylated deoxycholic (DCA) and cholic (CA) acids are potent ligands of pregnane X (PXR) receptor.
    Carazo A; Hyrsova L; Dusek J; Chodounska H; Horvatova A; Berka K; Bazgier V; Gan-Schreier H; Chamulitrat W; Kudova E; Pavek P
    Toxicol Lett; 2017 Jan; 265():86-96. PubMed ID: 27871908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric Antagonism of the Pregnane X Receptor (PXR): Current-State-of-the-Art and Prediction of Novel Allosteric Sites.
    Kamaraj R; Drastik M; Maixnerova J; Pavek P
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vitamin D receptor as a potential target for the toxic effects of per- and polyfluoroalkyl substances (PFASs): An in-silico study.
    Azhagiya Singam ER; Durkin KA; La Merrill MA; Furlow JD; Wang JC; Smith MT
    Environ Res; 2023 Jan; 217():114832. PubMed ID: 36403651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric binding on nuclear receptors: Insights on screening of non-competitive endocrine-disrupting chemicals.
    Zhang C; Wu J; Chen Q; Tan H; Huang F; Guo J; Zhang X; Yu H; Shi W
    Environ Int; 2022 Jan; 159():107009. PubMed ID: 34883459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proanthocyanidin B2 derived metabolites may be ligands for bile acid receptors S1PR2, PXR and CAR: an
    Hoang SH; Tveter KM; Mezhibovsky E; Roopchand DE
    J Biomol Struct Dyn; 2024 May; 42(8):4249-4262. PubMed ID: 37340688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D structures and ligand specificities of nuclear xenobiotic receptors CAR, PXR and VDR.
    Wu B; Li S; Dong D
    Drug Discov Today; 2013 Jun; 18(11-12):574-81. PubMed ID: 23299080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of farnesoid X, vitamin D, and pregnane X receptors: insights from the green-spotted pufferfish (Tetraodon nigriviridis) and other non-mammalian species.
    Krasowski MD; Ai N; Hagey LR; Kollitz EM; Kullman SW; Reschly EJ; Ekins S
    BMC Biochem; 2011 Feb; 12():5. PubMed ID: 21291553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary.
    Ding N; Harlow SD; Randolph JF; Loch-Caruso R; Park SK
    Hum Reprod Update; 2020 Sep; 26(5):724-752. PubMed ID: 32476019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How the Structure of Per- and Polyfluoroalkyl Substances (PFAS) Influences Their Binding Potency to the Peroxisome Proliferator-Activated and Thyroid Hormone Receptors-An In Silico Screening Study.
    Kowalska D; Sosnowska A; Bulawska N; Stępnik M; Besselink H; Behnisch P; Puzyn T
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of BDE-47 with nuclear receptors (NRs) based on the cytotoxicity: In vitro investigation and molecular interaction.
    Song J; Li Y; Zhao C; Zhou Q; Zhang J
    Ecotoxicol Environ Saf; 2021 Jan; 208():111390. PubMed ID: 33049448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of Per- and Polyfluoroalkyl Substances (PFAS) to the PPARγ/RXRα-DNA Complex.
    Almeida NMS; Bali SK; James D; Wang C; Wilson AK
    J Chem Inf Model; 2023 Dec; 63(23):7423-7443. PubMed ID: 37990410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational Study of Drugs Targeting Nuclear Receptors.
    Kenda M; Sollner Dolenc M
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32244747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon-chain length determines the binding affinity and inhibitory strength of per- and polyfluoroalkyl substances on human and rat steroid 5α-reductase 1 activity.
    Cui R; Ye L; Qiao X; Wang S; Zheng K; Yang J; Ge RS; Lin H; Wang Y
    Chem Biol Interact; 2024 May; 394():110987. PubMed ID: 38574835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of a panel of per- and polyfluoroalkyl substances (PFAS), fatty acids, and pharmaceuticals in peroxisome proliferator-activated receptor (PPAR) alpha, PPAR gamma, and estrogen receptor assays.
    Evans N; Conley JM; Cardon M; Hartig P; Medlock-Kakaley E; Gray LE
    Toxicol Appl Pharmacol; 2022 Aug; 449():116136. PubMed ID: 35752307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.